Sanofi/Re­gen­eron win a new tri­al on Pralu­ent patents; Bridge­Bio bankrolls $30M biotech start­up

→ Af­ter com­ing per­ilous­ly close to see­ing their PC­SK9 drug Pralu­ent jerked off the mar­ket, Sanofi and Re­gen­eron have won a new tri­al in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.